Li Li, Ying Wang, Yinqiu Gao, Shu Liu, Guangjing Yang, Xiaoying Lv, Ya Xuan Sun, Ying Wu, Jinlin Li, Jiayan Zhou, Guang Chen
{"title":"新型温控设备与标准化操作可通过调节深层肌肉厚度改善慢性背痛:多中心随机对照试验","authors":"Li Li, Ying Wang, Yinqiu Gao, Shu Liu, Guangjing Yang, Xiaoying Lv, Ya Xuan Sun, Ying Wu, Jinlin Li, Jiayan Zhou, Guang Chen","doi":"10.1002/ctd2.330","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Chronic back pain affected 619 million people globally in 2020 which accounts for a heavy disease burden causing tremendous productivity losses. Current therapies including ibuprofen, duloxetine, and opioids might cause side effects and even severe drug use disorders. Therefore, a non-pharmacologic therapy with better or equivalent efficacy and fewer side effects is needed.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We did a multi-center, single-blinded, randomized, positive drug controlled, clinical trial. Patients with chronic back pain in moderate severity were randomized into receiving hot stone massage or flurbiprofen plaster group. Both interventions were 2 weeks with a follow-up of 4 weeks. The primary outcome was the change in the score of the Global Pain Scale (GPS) from baseline to week 2. Secondary outcomes included Numerical Rating Scale (NRS), Chronic Pain Acceptance Questionnaire (CPAQ), Pain Self-Efficacy Questionnaire (PSEQ), Hospital Anxiety and Depression Scale (HADS), and Short Form-36 (SF36) from baseline to week 2 and week 6. Exploratory outcome assessment included the muscle thickness measured by ultrasound. Any adverse event was monitored throughout the study period.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 120 patients were enrolled in this trial. At 2 weeks GPS decreased significantly in the hot stone massage group compared to the flurbiprofen group (difference between groups = -8.1 points, 95% confidence interval [CI] -15.8 to -0.3, <i>p</i> = 0.047). Moreover, hot stone massage also showed more improvement at 2 weeks compared to flurbiprofen, including NRS (-0.5 points, 95% CI -1.0 to -0.1, <i>p</i> = 0.029), PSEQ (5.4 points, 95% CI 0.5 to 10.2, <i>p</i> = 0.030), and mental component of Short Form-36 (SF-36) (1.7 points, 95% CI 0.4 to 2.9, <i>p</i> = 0.010), but not in CPAQ (<i>p</i> = 0.131), HADS (<i>p</i> = 0.303 for depression, <i>p</i> = 0.399 for anxiety), or SF-36 (<i>p</i> = 0.129 for physical component, <i>p</i> = 0.246 for social component, <i>p</i> = 0.076 for fatigue component). A total of two participants in the hot stone massage group reported mild pain on skin surface when receiving the procedure at the first intervention session.</p>\n </section>\n </div>","PeriodicalId":72605,"journal":{"name":"Clinical and translational discovery","volume":"4 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctd2.330","citationCount":"0","resultStr":"{\"title\":\"A novel temperature-controlled device with standardized manipulation improves chronic back pain mediated by modulating deep muscle thickness: A multicenter randomized controlled trial\",\"authors\":\"Li Li, Ying Wang, Yinqiu Gao, Shu Liu, Guangjing Yang, Xiaoying Lv, Ya Xuan Sun, Ying Wu, Jinlin Li, Jiayan Zhou, Guang Chen\",\"doi\":\"10.1002/ctd2.330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Chronic back pain affected 619 million people globally in 2020 which accounts for a heavy disease burden causing tremendous productivity losses. Current therapies including ibuprofen, duloxetine, and opioids might cause side effects and even severe drug use disorders. Therefore, a non-pharmacologic therapy with better or equivalent efficacy and fewer side effects is needed.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We did a multi-center, single-blinded, randomized, positive drug controlled, clinical trial. Patients with chronic back pain in moderate severity were randomized into receiving hot stone massage or flurbiprofen plaster group. Both interventions were 2 weeks with a follow-up of 4 weeks. The primary outcome was the change in the score of the Global Pain Scale (GPS) from baseline to week 2. Secondary outcomes included Numerical Rating Scale (NRS), Chronic Pain Acceptance Questionnaire (CPAQ), Pain Self-Efficacy Questionnaire (PSEQ), Hospital Anxiety and Depression Scale (HADS), and Short Form-36 (SF36) from baseline to week 2 and week 6. Exploratory outcome assessment included the muscle thickness measured by ultrasound. Any adverse event was monitored throughout the study period.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 120 patients were enrolled in this trial. At 2 weeks GPS decreased significantly in the hot stone massage group compared to the flurbiprofen group (difference between groups = -8.1 points, 95% confidence interval [CI] -15.8 to -0.3, <i>p</i> = 0.047). Moreover, hot stone massage also showed more improvement at 2 weeks compared to flurbiprofen, including NRS (-0.5 points, 95% CI -1.0 to -0.1, <i>p</i> = 0.029), PSEQ (5.4 points, 95% CI 0.5 to 10.2, <i>p</i> = 0.030), and mental component of Short Form-36 (SF-36) (1.7 points, 95% CI 0.4 to 2.9, <i>p</i> = 0.010), but not in CPAQ (<i>p</i> = 0.131), HADS (<i>p</i> = 0.303 for depression, <i>p</i> = 0.399 for anxiety), or SF-36 (<i>p</i> = 0.129 for physical component, <i>p</i> = 0.246 for social component, <i>p</i> = 0.076 for fatigue component). A total of two participants in the hot stone massage group reported mild pain on skin surface when receiving the procedure at the first intervention session.</p>\\n </section>\\n </div>\",\"PeriodicalId\":72605,\"journal\":{\"name\":\"Clinical and translational discovery\",\"volume\":\"4 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctd2.330\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and translational discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ctd2.330\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and translational discovery","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctd2.330","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景 2020 年,全球将有 6.19 亿人受到慢性背痛的影响,这是一个沉重的疾病负担,会造成巨大的生产力损失。目前的疗法包括布洛芬、度洛西汀和阿片类药物,可能会导致副作用,甚至严重的药物使用障碍。因此,需要一种疗效更好或相当、副作用更小的非药物疗法。 方法 我们进行了一项多中心、单盲、随机、阳性药物对照临床试验。中度慢性背痛患者被随机分为热石按摩组和氟比洛芬膏药组。两项干预均为 2 周,随访 4 周。主要结果是整体疼痛量表(GPS)从基线到第2周的评分变化。次要结果包括从基线到第2周和第6周的数字评分量表(NRS)、慢性疼痛接受度问卷(CPAQ)、疼痛自我效能问卷(PSEQ)、医院焦虑和抑郁量表(HADS)以及短表-36(SF36)。探索性结果评估包括通过超声波测量肌肉厚度。在整个研究期间对任何不良事件进行监测。 结果 共有 120 名患者参加了这项试验。与氟比洛芬组相比,热石按摩组在2周时GPS明显下降(组间差异=-8.1分,95%置信区间[CI]-15.8至-0.3,P=0.047)。此外,与氟比洛芬相比,热石按摩在 2 周后也显示出更大的改善作用,包括 NRS(-0.5 分,95% CI -1.0 至 -0.1,p = 0.029)、PSEQ(5.4 分,95% CI 0.5 至 10.2,p = 0.030)和 Short Form-36 (SF-36) 的精神部分(1.7 分,95% CI 0.4 至 2.9,p = 0.010),但在 CPAQ(p = 0.131)、HADS(抑郁 p = 0.303,焦虑 p = 0.399)或 SF-36 (身体部分 p = 0.129,社交部分 p = 0.246,疲劳部分 p = 0.076)方面没有变化。在热石按摩组中,共有两名参与者表示在第一次接受干预治疗时皮肤表面有轻微疼痛。
A novel temperature-controlled device with standardized manipulation improves chronic back pain mediated by modulating deep muscle thickness: A multicenter randomized controlled trial
Background
Chronic back pain affected 619 million people globally in 2020 which accounts for a heavy disease burden causing tremendous productivity losses. Current therapies including ibuprofen, duloxetine, and opioids might cause side effects and even severe drug use disorders. Therefore, a non-pharmacologic therapy with better or equivalent efficacy and fewer side effects is needed.
Methods
We did a multi-center, single-blinded, randomized, positive drug controlled, clinical trial. Patients with chronic back pain in moderate severity were randomized into receiving hot stone massage or flurbiprofen plaster group. Both interventions were 2 weeks with a follow-up of 4 weeks. The primary outcome was the change in the score of the Global Pain Scale (GPS) from baseline to week 2. Secondary outcomes included Numerical Rating Scale (NRS), Chronic Pain Acceptance Questionnaire (CPAQ), Pain Self-Efficacy Questionnaire (PSEQ), Hospital Anxiety and Depression Scale (HADS), and Short Form-36 (SF36) from baseline to week 2 and week 6. Exploratory outcome assessment included the muscle thickness measured by ultrasound. Any adverse event was monitored throughout the study period.
Results
A total of 120 patients were enrolled in this trial. At 2 weeks GPS decreased significantly in the hot stone massage group compared to the flurbiprofen group (difference between groups = -8.1 points, 95% confidence interval [CI] -15.8 to -0.3, p = 0.047). Moreover, hot stone massage also showed more improvement at 2 weeks compared to flurbiprofen, including NRS (-0.5 points, 95% CI -1.0 to -0.1, p = 0.029), PSEQ (5.4 points, 95% CI 0.5 to 10.2, p = 0.030), and mental component of Short Form-36 (SF-36) (1.7 points, 95% CI 0.4 to 2.9, p = 0.010), but not in CPAQ (p = 0.131), HADS (p = 0.303 for depression, p = 0.399 for anxiety), or SF-36 (p = 0.129 for physical component, p = 0.246 for social component, p = 0.076 for fatigue component). A total of two participants in the hot stone massage group reported mild pain on skin surface when receiving the procedure at the first intervention session.